| Literature DB >> 29922184 |
Christian Puta1, Thomas Steidten1, Philipp Baumbach2, Toni Wöhrl1, Rico May3, Michael Kellmann4,5, Marco Herbsleb1, Brunhild Gabriel1, Stephanie Weber1, Urs Granacher6, Holger H W Gabriel1.
Abstract
From a health and performance-related perspective, it is crucial to evaluate subjective symptoms and objective signs of acute training-induced immunological responses in young athletes. The limited number of available studies focused on immunological adaptations following aerobic training. Hardly any studies have been conducted on resistance-training induced stress responses. Therefore, the aim of this observational study was to investigate subjective symptoms and objective signs of immunological stress responses following resistance training in young athletes. Fourteen (7 females and 7 males) track and field athletes with a mean age of 16.4 years and without any symptoms of upper or lower respiratory tract infections participated in this study. Over a period of 7 days, subjective symptoms using the Acute Recovery and Stress Scale (ARSS) and objective signs of immunological responses using capillary blood markers were taken each morning and after the last training session. Differences between morning and evening sessions and associations between subjective and objective parameters were analyzed using generalized estimating equations (GEE). In post hoc analyses, daily change-scores of the ARSS dimensions were compared between participants and revealed specific changes in objective capillary blood samples. In the GEE models, recovery (ARSS) was characterized by a significant decrease while stress (ARSS) showed a significant increase between morning and evening-training sessions. A concomitant increase in white blood cell count (WBC), granulocytes (GRAN) and percentage shares of granulocytes (GRAN%) was found between morning and evening sessions. Of note, percentage shares of lymphocytes (LYM%) showed a significant decrease. Furthermore, using multivariate regression analyses, we identified that recovery was significantly associated with LYM%, while stress was significantly associated with WBC and GRAN%. Post hoc analyses revealed significantly larger increases in participants' stress dimensions who showed increases in GRAN%. For recovery, significantly larger decreases were found in participants with decreases in LYM% during recovery. More specifically, daily change-scores of the recovery and stress dimensions of the ARSS were associated with specific changes in objective immunological markers (GRAN%, LYM%) between morning and evening-training sessions. Our results indicate that changes of subjective symptoms of recovery and stress dimensions using the ARSS were associated with specific changes in objectively measured immunological markers.Entities:
Keywords: Acute Recovery and Stress Scale (ARSS); immune system; strength training; track and field; youth
Year: 2018 PMID: 29922184 PMCID: PMC5996067 DOI: 10.3389/fphys.2018.00698
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Mini-Review of immunological responses in young athletes.
| Publication | Subjects | Method | Main measures | Period | ISR? | Acute or chronic? |
|---|---|---|---|---|---|---|
| 15 ml salvia samples | s-IgA | 1 week (2 official and 2 simulated matches) | yes | acute | ||
| 15 ml salvia samples, WURSS-21, Borg-Scale | s-IgA, URTI, RPE | 8 weeks training (1 familiarization, 4 intensive training, 3 taper) | yes | chronic | ||
| 15 ml salvia samples, Borg-Scale | s-IgA, Cortisol, RPE | 20 days (7 matches) | yes | chronic | ||
| 1 mL salvia, 2 mL blood samples | s-IgA, s-IgM, s-IgG, NK-Cells, Albumin | 12 weeks training | yes | chronic | ||
| 15 mL saliva samples, WURSS-21, Borg | s-IgA, URTI, RPE | 4 weeks training | no | chronic |
Marginal means and confidence intervals (95%CI) resulting from the Generalized Estimating Equation models for the dimensions of the Acute Recovery and Stress Scale (ARSS) and capillary blood markers.
| Morning | Evening | praw | padj | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Mean | 95% CI | Mean | 95% CI | ||||||
| ARSS: recovery | [0–5] | 4.46 | 4.10 | 4.82 | 4.01 | 3.67 | 4.36 | ||
| ARSS: stress | [0–5] | 0.91 | 0.63 | 1.20 | 1.51 | 1.13 | 1.89 | ||
| White blood cells | [109/l] | 7.41 | 6.88 | 7.95 | 9.26 | 8.16 | 10.36 | ||
| Lymphocytes | [109/l] | 2.98 | 2.64 | 3.33 | 3.14 | 2.79 | 3.48 | 0.363 | 0.999 |
| Lymphocytes | [%] | 40.55 | 37.33 | 43.76 | 35.10 | 32.50 | 37.71 | ||
| Monocytes | [109/l] | 0.63 | 0.58 | 0.67 | 0.75 | 0.65 | 0.85 | 0.063 | |
| Monocytes | [%] | 7.74 | 7.39 | 8.08 | 7.53 | 7.20 | 7.86 | 0.165 | 0.999 |
| Granulocytes | [109/l] | 3.79 | 3.43 | 4.15 | 5.36 | 4.59 | 6.14 | ||
| Granulocytes | [%] | 51.69 | 48.40 | 54.98 | 57.34 | 54.58 | 60.10 | ||
| Red blood cells | [1012/l] | 4.66 | 4.45 | 4.87 | 4.52 | 4.34 | 4.69 | 0.062 | |
| Hemoglobin | [mmol/l] | 8.70 | 8.34 | 9.05 | 8.46 | 8.15 | 8.76 | 0.052 | |
| Hematocrit | [%] | 38.80 | 37.33 | 40.28 | 37.68 | 36.42 | 38.95 | ||
| Mean corpuscular volume | [fl] | 83.22 | 82.21 | 84.22 | 83.33 | 82.43 | 84.24 | 0.450 | 0.999 |
| MCH | [fmol] | 1.87 | 1.84 | 1.90 | 1.87 | 1.85 | 1.90 | 0.382 | 0.999 |
| MCHC | [mmol/l] | 22.47 | 22.32 | 22.63 | 22.49 | 22.31 | 22.66 | 0.661 | 0.999 |
| Blood cell distribution width | [fl] | 52.26 | 51.29 | 53.24 | 52.53 | 51.58 | 53.47 | 0.194 | 0.999 |
| Red blood cell distribution width | [%] | 13.94 | 13.74 | 14.14 | 13.99 | 13.77 | 14.21 | 0.083 | 0.834 |
| Platelets | [109/l] | 136.49 | 119.34 | 153.63 | 137.36 | 121.61 | 153.11 | 0.870 | 0.999 |
| Platelet distribution width | [fl] | 12.72 | 12.13 | 13.31 | 12.91 | 12.25 | 13.56 | 0.205 | 0.999 |
| Large platelet | [%] | 22.05 | 19.98 | 24.11 | 22.60 | 20.18 | 25.01 | 0.250 | 0.999 |
Results of the univariate regression analysis using generalized estimating equations for the dimensions of the Acute Recovery and Stress Scale (ARSS).
| ARSS: stress | ARSS: recovery | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| β | 95%CI | β | 95%CI | ||||||
| White blood cells | 0.34 | 0.14 | 0.55 | -0.21 | -0.39 | -0.03 | |||
| Lymphocytes | 0.00 | -0.11 | 0.12 | 0.985 | 0.09 | -0.03 | 0.22 | ||
| Lymphocytes: percent | -0.41 | -0.62 | -0.19 | 0.38 | 0.18 | 0.59 | |||
| Monocytes | 0.20 | -0.01 | 0.41 | -0.09 | -0.27 | 0.08 | 0.294 | ||
| Monocytes: percent | -0.15 | -0.34 | 0.04 | 0.17 | -0.01 | 0.35 | |||
| Granulocytes | 0.40 | 0.19 | 0.62 | -0.29 | -0.49 | -0.08 | |||
| Granulocytes: percent | 0.40 | 0.19 | 0.62 | -0.38 | -0.58 | -0.18 | |||
| Red blood cells | -0.08 | -0.30 | 0.15 | 0.493 | 0.15 | -0.01 | 0.32 | ||
| Hemoglobin | -0.08 | -0.29 | 0.12 | 0.424 | 0.13 | -0.04 | 0.30 | ||
| Hematocrit | -0.07 | -0.27 | 0.12 | 0.468 | 0.12 | -0.03 | 0.28 | ||
| Mean corpuscular volume | 0.03 | -0.25 | 0.31 | 0.840 | -0.19 | -0.50 | 0.12 | 0.230 | |
| MCH | 0.02 | -0.30 | 0.34 | 0.894 | -0.17 | -0.45 | 0.11 | 0.238 | |
| MCHC | -0.02 | -0.18 | 0.15 | 0.829 | 0.01 | -0.16 | 0.19 | 0.868 | |
| Blood cell distribution width: absolute | 0.10 | -0.07 | 0.27 | 0.260 | -0.19 | -0.41 | 0.04 | ||
| Red blood cell distribution width: percent | 0.10 | -0.23 | 0.43 | 0.551 | -0.09 | -0.38 | 0.20 | 0.532 | |
| Platelets | 0.08 | -0.24 | 0.40 | 0.633 | -0.19 | -0.48 | 0.10 | 0.204 | |
| Platelet distribution width | 0.00 | -0.24 | 0.24 | 0.992 | -0.08 | -0.29 | 0.14 | 0.479 | |
| Large platelet: percent | -0.02 | -0.27 | 0.23 | 0.885 | -0.05 | -0.26 | 0.17 | 0.651 | |
Results of the multivariate regression analysis using Generalized Estimating Equations for the dimensions of the Acute Recovery and Stress Scale (ARSS).
| Unit | Model I | Model II | |||||||
|---|---|---|---|---|---|---|---|---|---|
| β | 95%CI | β | 95%CI | ||||||
| Lymphocytes: percent | 0.38 | 0.18 | 0.59 | <0.001 | was not entered because of high multicollinearity | ||||
| Granulocytes: percent | was not entered because of high multicollinearity | -0.39 | -0.59 | -0.19 | <0.001 | ||||
| Blood cell distribution width: absolute | -0.20 | -0.43 | 0.04 | 0.098 | -0.21 | -0.43 | 0.02 | 0.073 | |
| -0.07 | -0.47 | 0.33 | 0.738 | -0.07 | -0.47 | 0.33 | 0.729 | ||
| White blood cells | 0.22 | 0.05 | 0.38 | 0.010 | 0.22 | 0.06 | 0.38 | 0.006 | |
| Lymphocytes: percent | -0.31 | -0.51 | -0.11 | 0.002 | was not entered because of high multicollinearity | ||||
| Granulocytes: percent | was not entered because of high multicollinearity | 0.31 | 0.12 | 0.50 | 0.001 | ||||